Dopamine and the diseased brain
- PMID: 16613557
- DOI: 10.2174/187152706784111560
Dopamine and the diseased brain
Abstract
Dysfunction of central dopaminergic neurotransmission has been implicated in a series of neuropsychiatric disorders, including Tourette's syndrome, schizophrenia, and drug and alcohol dependence. The behavioral and psychopathological manifestations of central dopaminergic dysfunction differ depending on the site of their neurobiological correlate. These sites may be found in the dorsal or ventral striatum, but also in cortical regions such as the limbic and prefrontal cortex, among other locations. A low basic dopamine turnover and an increase in the availability of dopamine D2 receptors in the caudate body have been associated with the severity of motor tics in Tourette's syndrome. In the ventral striatum and particularly in the nucleus accumbens, different drugs of abuse stimulate dopamine release and thus reinforce drug consumption. The downregulation of dopamine D2 receptors in this area of the brain has been associated with alcohol craving and an increase in the processing of alcohol-related stimuli in the medial prefrontal cortex. Brain imaging studies in which intrasynaptic dopamine release is manipulated in vivo have shown that increased subcortical dopamine release is associated with the pathogenesis of positive symptoms in schizophrenia. This review discusses a broad range of brain imaging and neuroendocrinological studies on dopaminergic dysfunction in neuropsychiatric disorders, including relevant findings on the basis of primate studies. In addition, the hypothesis is examined that phasic dopamine release is associated with salience attribution to external stimuli, insofar as it mediates reward anticipation in the ventral striatum and limbic cortex, habit formation in the dorsal striatum, and working memory function in the prefrontal cortex.
Similar articles
-
Dopaminergic dysfunction in alcoholism and schizophrenia--psychopathological and behavioral correlates.Eur Psychiatry. 2002 Mar;17(1):9-16. doi: 10.1016/s0924-9338(02)00628-4. Eur Psychiatry. 2002. PMID: 11918987 Review.
-
Correlation between dopamine D(2) receptors in the ventral striatum and central processing of alcohol cues and craving.Am J Psychiatry. 2004 Oct;161(10):1783-9. doi: 10.1176/appi.ajp.161.10.1783. Am J Psychiatry. 2004. PMID: 15465974
-
Altered mesolimbocortical and thalamic dopamine in Tourette syndrome.Neurology. 2006 Nov 14;67(9):1695-7. doi: 10.1212/01.wnl.0000242733.18534.2c. Neurology. 2006. PMID: 17101911
-
In vivo imaging of synaptic function in the central nervous system: II. Mental and affective disorders.Behav Brain Res. 2009 Dec 1;204(1):32-66. doi: 10.1016/j.bbr.2009.06.009. Epub 2009 Jun 10. Behav Brain Res. 2009. PMID: 19523495 Review.
-
Increased synaptic dopamine function in associative regions of the striatum in schizophrenia.Arch Gen Psychiatry. 2010 Mar;67(3):231-9. doi: 10.1001/archgenpsychiatry.2010.10. Arch Gen Psychiatry. 2010. PMID: 20194823
Cited by
-
Nanozyme-based sensing of dopamine using cobalt-doped hydroxyapatite nanocomposite from waste bones.Front Bioeng Biotechnol. 2024 Apr 17;12:1364700. doi: 10.3389/fbioe.2024.1364700. eCollection 2024. Front Bioeng Biotechnol. 2024. PMID: 38694624 Free PMC article.
-
Cue-induced reinstatement of seeking behavior in male rats is independent from the rewarding value of the primary reinforcer: Effect of mGluR5 blockade.Neuropharmacology. 2023 Dec 1;240:109694. doi: 10.1016/j.neuropharm.2023.109694. Epub 2023 Sep 1. Neuropharmacology. 2023. PMID: 37659439 Free PMC article.
-
Acute and Lifetime Stress and Psychotic Illness: The Roles of Reward and Salience Networks.J Psychiatr Brain Sci. 2022;7(6):e220012. doi: 10.20900/jpbs.20220012. Epub 2022 Dec 30. J Psychiatr Brain Sci. 2022. PMID: 36741029 Free PMC article.
-
Association of Alcohol Use Disorder Risk With ADH1B, DRD2, FAAH, SLC39A8, GCKR, and PDYN Genetic Polymorphisms.In Vivo. 2022 Sep-Oct;36(5):2092-2104. doi: 10.21873/invivo.12935. In Vivo. 2022. PMID: 36099111 Free PMC article.
-
Aptamer-Based Biosensors for the Colorimetric Detection of Blood Biomarkers: Paving the Way to Clinical Laboratory Testing.Biomedicines. 2022 Jul 6;10(7):1606. doi: 10.3390/biomedicines10071606. Biomedicines. 2022. PMID: 35884911 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical